510(k) device
multiFiltratePRO System
Fresenius Medical Care Renal Therapies Group, LLC · Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI, Class II) · First FDA decision Dec 16, 2022, newest Oct 19, 2026Kidney failure and dialysis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
4
Naming "multiFiltratePRO"
MAUDE reports
83
Brand "multiFiltratePRO", since 2015
PubMed studies
0
Mentioning "multiFiltratePRO"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing multiFiltratePRO System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- multiFiltratePRO System510(k)
K261203 · Decided Oct 19, 2026 · 189 days after receipt
Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI) · GI, Urology & Nephrology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "multiFiltratePRO", any status and sponsor, newest update first.
- Analysis of TPE Treatments With multiFiltratePROActive, not recruiting
Fresenius Medical Care Deutschland GmbHNot on our public-company list
NCT06272084 · 60 participants (planned) · Start May 22, 2024 · Primary completion Feb 22, 2026
Device: Therapeutic Plasma Exchange (TPE) option of multiFiltratePRO · For: Autoimmune Diseases
Sites: Aschaffenburg, Germany; Würzburg, Germany; Berlin, Germany
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "multiFiltratePRO", and for the whole product code for context.
This brand
83 reports: 79 malfunction, 2 injury, 2 death
Whole product code KDI
25,025 reports: 21,247 malfunction, 2,993 injury, 752 death
Newest reports for this brand
- DISC MULTIFILTRATEPRO HDFMalfunction
0001225714-2025-00012 · Received Mar 11, 2025 · Event dated Feb 13, 2025
Device type: Set, Tubing, Blood, With And Without Anti-Regurgitation Valve (FJK)
Device problem as coded: Fluid/Blood Leak
Patient problem as coded: Hemorrhage/Blood Loss/Bleeding
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "multiFiltratePRO"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code KDI.
- NxStage System One with Cartridge Express (CAR-170-E and CAR-172-E)Nxstage Medical, Inc. · 510(k) 2024
- Tablo Hemodialysis System (PN-0008000, PN-0006000U)Outset Medical, Inc. · 510(k) 2026
- Aquadex FlexFlow System 2.0Chf Solutions, Inc. · 510(k) 2020
- NxStage Cartridge Express with SpeedswapNxstage Medical, Inc. · 510(k) 2019
- Venofer PumpRenal Solutions, Inc. · 510(k) 2012
- Elisio-HNipro Medical Corporation · 510(k) 2026
- FX CorAL 40Fresenius Medical Care Renal Therapies Group, LLC · 510(k) 2025
- FX CorAL 60 (F00012969)Fresenius Medical Care Renal Therapies Group, LLC · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.